Step Pharma announces promising pre-clinical cancer data : v

​​Step Pharma says pre-clinical data on its first-in-class, highly selective, orally bioavailable CTPS1 inhibitor, STP938 is encouraging. 

Related Keywords

Louisiana , United States , New Orleans , American , Andrew Parker , American Society Of Hematology , Step Pharma , American Society ,